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Abstract
Background: No previous studies have examined the effect of pregnancy-induced hypertension
(PIH) on early infant growth. The objective was to study infant growth patterns of babies born to
mothers with PIH at 28 and 42 days postpartum.
Methods: Design: We conducted a population-based retrospective cohort study of 16,936
pregnancies delivered between January 1, 1989 through December 31, 1990 in Suzhou, China. PIH
was classified as gestational hypertension, preeclampsia and severe preeclampsia. Infant Growth
Percentage (IGP) was calculated as the weight gain from birth to infant weight at 28 or 42 days
postpartum divided by the birth weight. Univariate analysis and multivariate linear regression were
performed to compare the infant weight as well as IGP at 28 and 42 days postpartum between
various types of PIH and the normotensive group.
Results:  Infant weights at 28 and 42 days postpartum were significantly lower in severe
preeclampsia (e.g., 4679.9 g at 42 days) and preeclampsia (e.g., 4763.8 g at 42 days) groups than in
the normotensive group (e.g., 4869.1 g at 42 days, p < 0.01). However, there were no differences
in IGP between groups. After stratifying by intrauterine growth restriction (IUGR) status, if babies
were not intrauterine growth restricted, none of the PIH types showed a significantly lower weight
at 28 and 42 days postpartum and their IGPs were similar to those of the reference group. When
babies were growth restricted, all PIH groups showed significantly lower weights but higher IGP at
28 and 42 days postpartum as compared to the normotensive group.
Conclusion: Infants born to mothers with PIH but without IUGR have normal early infant growth.
IUGR secondary to PIH is associated with significant catch-up growth at 28 and 42 days
postpartum.
Background
Pregnancy-induced hypertension (PIH), especially preec-
lampsia, is a major cause of maternal and perinatal mor-
bidity and mortality worldwide [1,2]. The impact of PIH
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on birth outcomes has been extensively studied. However,
the potential long-term effect of PIH on infants born to
PIH mothers has been less studied. PIH has been con-
firmed to increase significantly the risk of low birth weight
by both increasing preterm birth as well as reducing fetal
growth. On the other hand, PIH has been found to be
associated with an increased rate of high birth weight and
large-for-gestational age babies [3,4]. These findings sug-
gest that PIH, more specifically preeclampsia, is a hetero-
geneous syndrome and that preeclampsia may appear in
two forms: restricted fetal growth preeclampsia and nor-
mal fetal growth preeclampsia [4-7]. PIH may have differ-
ent short and long term effects on infant growth between
these possible two types of preeclampsia by intrauterine
growth restriction (IUGR) [5,6]. Low birth weight or
IUGR babies have been associated with the occurrence of
several chronic diseases such as cardiovascular diseases in
later life [8-10]. However, the hypothesis of the fetal ori-
gins of adult disease is still the subject of debate [11,12].
One argument is that maternal risk factors in pregnancy
(such as PIH) and environmental risk factors in the post-
partum period can contribute to this life-long develop-
ment of the chronic disorders. A change in infant growth
of the IUGR baby itself (e.g. catch-up growth) such as in
the critical early infant period may also have long-term
effects on health later in life, and this change of postpar-
tum growth may be influenced by PIH. Therefore, it is
important to study postpartum infant growth patterns of
babies born to mothers with PIH, and to determine if
there are differences in infant growth between babies with
and those without IUGR. However, to date, there have
been few studies on the effects of PIH on infant growth.
The objective of this study was to examine the effects of




We conducted a retrospective cohort study based on a
population-based perinatal database from Suzhou,
China. The database was previously described by Xiong et
al [3,13]. In brief, data used in this analysis were popula-
tion-based, collected in all 10 hospitals in the city,
including16,936 pregnant women from January 1, 1989
through December 31, 1990. We excluded patients with
multiple pregnancies (212 cases), chronic cardiovascular
disease (36 cases), chronic renal disease or a history of
renal disease (303 cases), chronic hypertension or history
of hypertension (59 cases), and abnormal blood pressure
(diastolic pressure ≥  90 mmHg or systolic pressure ≥  130
mmHg) at the first prenatal visit before 21 weeks (850
cases) and abnormal blood pressure after 42 postpartum
days (988 cases). There were 2,567 women with no or
missing information on infant weight at 28 days or 42
days postpartum, including 105 women who had still-
births, 138 women who had infant deaths up to 28 days
postpartum and 2,324 women who were lost to follow-
up. After exclusions, a total of 11,921 pregnancies were
retained for the analysis.
Definition of pregnancy-induced hypertension
PIH was classified as gestational hypertension, preeclamp-
sia, severe preeclampsia or eclampsia. According to the
Chinese criteria [14], gestational hypertension was
defined as a blood pressure equal to or greater than 130/
90 mmHg on more than two occasions greater than six
hours apart without proteinuria after 21 weeks of gesta-
tion. Preeclampsia was diagnosed as hypertension of
equal or greater than 130/90 mmHg but less than 160/
110 mmHg with proteinuria of 1+ or 2+ on dipstick in
two samples 6 hours apart or greater than 0.3 grams in a
24-hour urine collection. Severe preeclampsia was diag-
nosed when preeclampsia was complicated by a systolic
pressure of ≥  160 mmHg or diastolic pressure ≥  110
mmHg and/or if proteinuria was greater than 2+ on dip-
stick or 5 grams in 24-hour urine collection. Eclampsia
was defined as seizure occurred in patients with preec-
lampsia. Patients with eclampsia were grouped with the
severe preeclampsia group for analysis. We restricted our
focus to PIH, therefore, pregnancies complicated by
chronic hypertension and preeclampsia superimposed on
chronic hypertension were not studied.
Definition of outcomes and confounding variables
Birth weight was measured in grams at birth. Infant
weight was measured at 28 and 42 days postpartum. Ges-
tational age was determined by the obstetricians on the
basis of the information on menstrual history, physical
examination or early ultrasound examination. IUGR was
defined as birth weight below the tenth percentile of
expected weight for gestational age [15]. Infant weight at
28 days was measured as the standardised medical proce-
dures during the third postpartum home visit by person-
nel from the community clinic near the newborn's home.
Infant weight at 42 days postpartum was measured in hos-
pital during the last day of perinatal care examination
while registering for the beginning of the infant care. We
developed an index of Infant Growth Percentage (IGP) to
measure the infant growth rate. IGP at 28 days is defined
as [(infant weight 28 days - birth weight) / birth weight] ×
100% and so is the IGP at 42 days by [(infant weight 42
days - birth weight) / birth weight] × 100%. Infant com-
plications were defined as at least one of respiratory dis-
tress, newborn fever, birth injury, jaundice, sclerema, cord
infection and intra-cranial bleeding. Other potential con-
founding variables include maternal age, body mass index
[weight (kg)/height(m)2], infant's sex, pre-pregnancy or
gestational diabetes mellitus and maternal anemia.BMC Pregnancy and Childbirth 2005, 5:10 http://www.biomedcentral.com/1471-2393/5/10
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Statistical analysis
Mean birth weight and infant weights at 28 and 42 days
postpartum were compared by a variance of analysis
between different PIH groups. First, the three groups with
PIH disorders were compared to the normotensive refer-
ent group. Then each PIH group was further divided into
two subgroups according to the existence of IUGR and the
same analysis performed using normotensive pregnancies
without IUGR as the referent group. Post hoc pair-wise
multiple comparisons, which test which specific means
differ significantly from others, were performed by Tukey
and Bonferroni procedures [16]. In order to assess the
independent effect of PIH on infant weight at 28 and 42
days postpartum respectively, multiple linear regression
analysis was performed to adjust for confounding varia-
bles [16,17]. Infant weight at 28 days and 42 days were the
dependent variables. Dummy variables of severe preec-
lampsia with and without IUGR, preeclampsia with and
without IUGR, gestational hypertension with and without
IUGR, normotensive status with and without IUGR, and
other confounding variables were independent variables.
The regression coefficients (β ) are estimated by the
method of least squares [16]. The statistical significance
(p-value) of β  was also tested. All statistical analyses were
performed with SPSS 10.0 for Windows (SPSS Inc., Chi-
cago, IL).
Table 1: Demographic and reproductive characteristics of study population by pregnancy-induced hypertension, Suzhou, China, 1989–
1990
Subjects













≤ 30 11,230 94.2 94.6 90.3 91.5 94.3 0.000
> 30 691 5.8 5.4 9.7 8.5 5.7
Parity
Nulliparous 11,365 95.3 95.3 94.9 97.8 97.1 0.100
Multiparous 556 4.7 4.7 5.1 2.2 2.9
Sex
Male 6,026 50.5 50.8 48.6 47.4 55.2 0.290
Female 5,895 49.5 49.2 51.4 52.6 44.8
Preterm birth (<37 weeks)
No 11,527 96.7 96.6 98.2 96.7 93.3 0.023
Yes 394 3.3 3.4 1.8 3.3 6.7
Low birth weight (<2,500 g)
No 11,620 97.5 97.6 97.3 95.1 92.4 0.000
Yes 301 2.5 2.4 2.7 4.9 7.6
Mean gestational age (Weeks) 39.30 39.29 39.44 39.30 38.69 0.000 (Analysis of variance)
Place of delivery
Hospital 11,900 99.8 99.8 99.7 100 100 0.981
Home 11 0.1 0.1 0.1 0 0
BMI
< 24 11,012 92.8 93.1 90.0 89.6 93.3 0.005
24–28 426 3.6 3.4 5.3 5.8 4.8
> 28 432 3.6 3.5 4.7 4.6 1.9
Infant complications No Yes
No 10,989 93.1 93.1 90.9 87.0 88.5 0.000
Yes 810 6.9 6.4 9.1 13.0 11.5
* Excluding cases with missing information.BMC Pregnancy and Childbirth 2005, 5:10 http://www.biomedcentral.com/1471-2393/5/10
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Results
Table 1 summarizes the demographic and reproductive
characteristics of the women classified in each of the cate-
gories of the three PIH groups. Among the11,921 preg-
nant women, PIH occurred in 1,252 women (10.5 %).
Mean maternal age at delivery was 25.8 years, 95.3 % of
women were nulliparous. Almost all women gave birth at
hospital (99.8 %). Mean (± SD) gestational age at delivery
was 39.30 weeks (± 1.55 weeks), with a shorter gestational
age for severe preeclampsia. The incidences of preterm
birth (<37 weeks of gestation) and low birth weight
(<2,500 g) were significantly higher among babies born to
mothers with preeclampsia and severe preeclampsia than
normotensive women. Infant complications occurred in 7
% of babies and were more frequent in preeclampsia and
severe preeclampsia groups.
Table 2 presents the overall effects of PIH on infant
growth at 28 and 42 days postpartum. The infant weights
were statistically significantly lower in infants born to
mothers with both preeclampsia and severe preeclampsia
than infants born to normotensive mothers. However,
IGPs were not different between groups. For example, at
42 days postpartum, weights were significantly lower for
the preeclampsia and severe preeclampsia groups than for
normotensive group (mean weight = 4,763 g and 4,679 g
Table 2: Pregnancy-induced hypertension and infant weight at 28 and 42 days postpartum, univariate analysis
Infant growth 28 days postpartum Infant growth 42 days postpartum
Mean birth weight 
(g)
SD† Infant weight 
(g)




SD Infant growth 
percent 2 (%)
Normotensive (N=10,669) 3252.4 (Referent) 416,1 4088.8 (Referent) 496.2 25.7 4869.1 (Referent) 609.9 49.7
GH# (N=782) 3288.8 448.9 4084.1 540.4 24.2 4878.6 696.2 48.3
PE¶ (N=365) 3224.9 465.8 4018.6* 513.7 24.6 4763.8** 631.8 47.7
Severe PE (N=105) 3170.9 502.9 3941.9* 564.9 24.3 4679.9** 727.3 47.6
Total (N=11,921) 3253.2 420.9 4085.0 500.7 25.6 4864.8 618.2 49.5
* p < 0.05, ** p < 0.01
1 [(Infant weight 28 days - birth weight) / birth weight] × 100 %, 2 [(Infant weight 42 days - birth weight) / birth weight] × 100 %
† SD: standard deviation, #GH: gestational hypertension, ¶PE: preeclampsia.
Table 3: Pregnancy-induced hypertension and infant weight at 28 and 42 days postpartum by newborn IUGR status, univariate analysis





















830.3 25.2 (Referent) 4905.8 (592.9) 
(Referent)
1609.2 48.8 (Referent)






937.9 37.3** 4255.8 
(563.3)**
1742.6 69.3**




4143.6 (500.4) 790.5 23.6 4929.4 (665.8) 1576.3 47.0




857.5 34.7** 4231.6 
(754.3)**
1761.8 71.3**
PE¶/ non-IUGR (N=326) 3314.9 (401.8) 4091.3 (463.8) 776.4 23.4 4853.1 (572.9) 1537.2 46.4




938.3 37.9** 4025.4 
(624.2)**
1553.3 62.8**
Severe PE / non-IUGR 
(N=91)
3285.2 (434.8) 4037.4 (518.9) 752.2 22.9 4801.8 (682.8) 1516.6 46.2






892.8 36.8** 3882.1 
(463.5)**
1453.6 59.8
Total (N=11,921) 3253.2 (420.9) 4085.0 (500.7) 831.8 25.6 4864.8 (618.2) 1611.6 49.5
* p < 0.05, ** p < 0.01
1 [(Infant weight 28 days - birth weight) / birth weight] × 100 %, 2 [(Infant weight 42 days - birth weight) / birth weight] × 100 %
#GH: gestational hypertension, ¶PE: preeclampsia, ‡ IUGR: intrauterine growth restriction.
† SD: standard deviationBMC Pregnancy and Childbirth 2005, 5:10 http://www.biomedcentral.com/1471-2393/5/10
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vs. 4,869 g, p < 0.001), but no evidence of catch-up
growth in infants born to mothers with preeclampsia and
severe preeclampsia (IGP = 47.7% and 48.3% vs. 49.7%,
p = 0.618).
Table 3 presents the effect of PIH on growth at 28 and 42
days postpartum, stratified for the presence or absence of
intrauterine growth restriction (IUGR). Infant weights
were not different between infants born to mothers with
any types of PIH without IUGR and normotensive babies
without IUGR, and IGPs were not different between any
types of PIH and non-IUGR normotensive control. Con-
versely, infant weights were markedly lower in all infants
with IUGR than normotensive controls without IUGR.
Infant weight gains and IGPs were higher in any types of
PIH and normotensive control with IUGR than in their
counterpart groups without IUGR. For example, at 42 days
postpartum, in the absence of IUGR, there were no differ-
ences in infant weight between any of the types of PIH
(ranging from 4,801 g to 4,929 g) and non-IUGR normo-
tensive group (4,905 g). The IGPs were not different
between any types of PIH (ranging from 46.2 % to 47.0
%) and non-IUGR normotensive control (48.6%). How-
ever, in the presence of IUGR, infant weights were markedly
lower in the three types of PIH (ranging from 3,882 g to
4,231 g) and in normotensive (4,255 g) groups than in
non-IUGR normotensive control group (4,905 g), p <
0.001. The IGPs were significantly higher (ranging from
59.8% to 71.3%) as compared to the reference group
(48.8%), suggesting a significant catch-up growth.
Table 4 presents mean birth weight differences, infant
weight differences at 28 days and 42 days postpartum
between various types of PIH with and without IUGR and
the normotensive control group without IUGR, as well as
the corresponding regression coefficients (i.e., the weight
differences after adjustment for confounders). The results
of multivariate linear regression were consistent with
those of univariate analysis (Table 3). After adjustment for
confounding variables, IUGR babies born to any of the
PIH groups had significantly lower infant weights at 28
and 42 days postpartum. For example, there was a 903 g
(1,023 g before the adjustment for confounders) reduc-
tion in infant weight at 42 days postpartum in IUGR
babies born to severe preeclamptic mothers relative to
non-IUGR babies born to mothers with normal blood
pressure, although the IGP was higher in the IUGR babies.
Discussion
To our knowledge, there is no previous study that has
examined the effect of PIH on infant growth in the early
infant period. Our study found that when babies were
born with IUGR, all PIH groups had lower infant weight
and significant 'catch-up' growth at 28 and 42 days post-
partum. However, if babies were not born with IUGR, any
type of PIH did not have detrimental effect on infant
Table 4: Pregnancy-induced hypertension and infant weight at 28 and 42 days postpartum, multivariate analysis
Mean birth Infant weight 28 days postpartum Infant weight 42 days postpartum
Mean birth weight 
difference (g)
β  (SE)§ Infant weight 
difference (g)






Ref. Ref. Ref. Ref. Ref. Ref.
Normotensive / 
IUGR (N=602)
783.4** 776.2 (15.4)** 675.8** 640.0 (19.4)** 650.0** 619.4 (25.2)**
GH# / non-IUGR 
(N=725)
-56.6** -34.0 (14.0) -16.7 -4.4 (18.6) -23.7 -12.8 (22.8)
GH / IUGR 
(N=57)
826.7** 825.4 (49.0)** 799.5** 815.1 (61.8)** 674.2** 678.9 (80.1)**
PE¶/ non-IUGR 
(N=326)
-18. 4 -6.97 (20.5) 35.6 38.0 (25.8) 53.6 55.4 (33.5)
PE / IUGR (N=39) 824.5** 795.9 (60.3)** 716.5** 654.1 (76.0)** 880.4** 835.2 (98.7)**
Severe PE / non-
IUGR (N=91)
11.4 -20.0 (38.8) 89.5 39.4 (48.9) 104.0 69.9 (63.5)
Severe PE / IUGR 
(N=14)
868.0** 796.8 (92.4)** 805.5 674.7 (116.5)** 1023.6** 903.0 (151.2)**
* p < 0.05; ** p < 0.01
§β , coefficient, SE, standard error; adjusted for maternal age, body mass index, diabetes, infant's sex, maternal anemia, gestational age
#GH: gestational hypertension, ¶PE: preeclampsia, ‡ IUGR: intrauterine growth restrictionBMC Pregnancy and Childbirth 2005, 5:10 http://www.biomedcentral.com/1471-2393/5/10
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growth at 28 and 42 days postpartum. Our study suggests
that PIH per se does not affect early infant growth.
The finding of different effects of PIH on early infant
growth according to the presence of IUGR further sup-
ports the hypothesis that preeclampsia is a heterogeneous
disorder and present at least two subtypes: IUGR vs. nor-
mal fetal growth preeclampsia [4-6]. These two subtypes
of preeclampsia may have different pathogeneses, clinical
manifestations and short and long term effects on both
infants and mothers [4-7]. Patients with preeclampsia
who have IUGR babies may have placental dysfunction
such as reduced utero-placental perfusion as the common
pathogeneses. The present study shows this group of
infants has sustained lower weight in the early infant
period. In contrast, patients with preeclampsia who have
babies with normal fetal growth may not have the signifi-
cant placental dysfunction, thus have normal intrauterine
as well as early infant growth.
Newborns with poor intrauterine growth often demon-
strate postnatal catch-up growth [18,19]. Our study
suggests such a catch-up growth is initiated soon after
birth. The impact of catch-up growth on infant's long-
term health remains unclear. There is a dilemma as to
whether this catch-up growth, either inherent to IUGR
babies or through growth promotion programs as pro-
moted in many developing countries, is good or bad. In
short term, such a catch-up growth enables infants to
accelerate growth in order to reach their normal growth
curve, resulting in reduced infant morbidity and mortality
[19]. However, it has been suggested that catch-up growth
could have a detrimental influence, leading to the onset of
certain chronic diseases in later life [20-23]. The crucial
time for the development of long-term consequences is
the early postnatal period when catch-up growth occurs in
around 80 % of IUGR babies [18,22]. Some studies
[8,12,20,22] found that hypertension, cardiovascular dis-
eases and mellitus diabetes in adult life were correlated
with the existence of a low birth weight and a catch-up
growth in the early postnatal period. The hypothesis of
the fetal origins of adult disease [10,24,25] may be rede-
fined to consider the impact of the early infant period on
the risk of adult diseases [22,23]. Our study indicates that
for the infants born to mothers with various types of PIH,
only those babies with IUGR showed a catch-up growth.
Future long-term follow up studies are needed to examine
if IUGR babies born to PIH mothers are at higher risk to
develop certain adult diseases later in life than those non-
IUGR babies born to PIH mothers.
Several limitations of this study have to be addressed.
First, our database does not have information on impor-
tant factors such as maternal smoking and breastfeeding.
The prevalence of smoking is high for men in China, how-
ever, reported smoking is rare among women (<0.5%)
[26]. Therefore, our results are not likely to be biased by
not controlling for smoking. To our knowledge, almost all
women breast-fed their infants at that time. However, it is
possible that the presence of PIH or IUGR affected breast-
feeding and thereby early infant growth. Second, the data-
base has many cases with missing information on weight
at 28 days and/or 42 days postpartum. We compared
these missing cases with those pregnant women remained
for analysis. The rate of preterm birth and low birth
weight were higher in missing cases than in the remained
study population. This is partly due to women who had
perinatal deaths up to 28 days postpartum (most of those
babies were preterm, IUGR, or low birth weight) and thus
had no information on infant weight at 28 and 42 days
postpartum were classified into missing cases. This is the
reason why the study population has fewer preterm birth,
low birth weight and intrauterine restriction infants.
However, there were no significant differences in demo-
graphic and reproductive characteristics such as preg-
nancy-induced hypertension, maternal age, parity,
number of prenatal visits, infant's sex and gestational age.
Third, weight can be a good growth indicator but, ideally,
should be correlated to height and head circumference
[27], in order to differentiate between symmetrical and
non-symmetrical IUGR. We only considered weight as a
measure of growth pattern because it was the only availa-
ble variable.
Conclusion
The effect of PIH on early infant growth is dependent on
whether or not a baby is intrauterine growth restricted.
IUGR secondary to PIH is associated with significant
catch-up growth in early infant period. Therefore, we spec-
ulate that IUGR babies born to mothers with PIH may be
at higher risk to develop certain chronic diseases in their
later life. More studies in North American or European
populations are needed to confirm these results.
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